1. Stent for Life - John Kanakakis1*, MD, PhD; Argyrios Ntalianis2, MD, PhD; Georgios Papaioannou3, MD, MPH; Stavroula Hourdaki4; George Parharidis5, MD, PhD 1. SFL , , , , , (Department of Clinical Therapeutics, University of Athens, Alexandra Hospital, Athens, Greece); 2. , , , (Third Department of Cardiology, University of Athens, Athens, Greece); 3. , , ( Athens Medical Center, Athens, Greece); 4. SFL ( SFL project manager, Greece); 5. , , ( Interbalkan Medical Center, Thessaloniki, Greece). * : , , (Department of Clinical Therapeutics, University of Athens, Alexandra Hospital, Vas. Sofias and Lourou 1, GR-11528 Athens, Greece). E-mail: jkanakakis@yahoo.gr () ST (ST). Stent for Life (SFL) . , ST (Athens), , (Patras) - , ST ( 9% 32%). (Athens), 60% , ST. , -. , - . () , (1). () ST , (ESCARDIO guidelines) (2). , (3). ST 30 (1). , , (European Association of Percutaneous Cardiovascular Interventions) EuroPCR (European Society of Cardiology Working Group on Acute Cardiac Care) Stent for Life (SFL).

2. . SFL , . SFL ST. Stent for Life SFL SFL 2009 . , (Hellenic Society of Cardiology), (Ministry ofHealth) (). SFL , SFL . 20 , SFL, , . , , (Board of the Hellenic Society ofCardiology), (Ministry of Health) . - : (Athens), (40% ), (Patras) --, - 750000 . (Athens) ST -: ; -; >5 . ; , ; , -. , , , 2008 2010 (Hellenic Working Group of Interventional Cardiology) . SFL , 2011 . . , . 16778 -, 22% (3733) . 3. 21687 . ST 11731 ST (ST) 9956. ST ( ) ST (72,12%). () ST (40,3%), (41%). , SFL (31,82% 9%) (4). , 44% ( 50% 27,88%) ( 1). (Athens), 59,5% 25% ST, , (15,5%). (Patras) , ST. 7,4% , 6,4% . 1. ST Stent for Life ST 2. ST, , , . ST 4%. 4. 2. ST . , , 140 . , 37,9% ST , SFL (17%). - ST 129,11 . -, - , 53,41 . 182,52 . , -. , 62,17. , ST . SFL. , ST (Athens) (Patras). -. 40% (Athens), 59% ST. , . ST ST , (1) (5), ST ST. 5. , (4), . , , . 2011. (2008-2010 .). ( 44%) ST. (Athens) (60%), -. SFL ( >70% ST) . - . . ST, , (6-10). , , . . , - , (37.9%) (17%). SFL, ST , , . Stent for Life , , , , , - - ST . (ACT NOW - SAVE A LIFE) , -. (182 .). , . ST - (11-13). , ST , - . ( 12 , ) . , - . - . . 6. 3-24 (14). , , , . , ST. . , , . , , , . SFL . -, ST, Stent for Life ST. . 1. Widimsky P, Wijns W, Fajadet J, de Belder M, Knot J, Aaberge L, Andrikopoulos G, Baz JA, BetriuA, Claeys M, Danchin N, Djambazov S, Erne P, Hartikainen J, Huber K, Kala P, Klinceva M, SteenKristensen D, Ludman P, Ferre JM, Merkely B, Milicic D, Morais J, Noc M, Opolski G, Ostojic M,Radovanovic D, De Servi S, Stenestrand U, Studencan M, Tubaro M, Vasiljevic Z, Weidinger F,Witkowski A, Zeymer U. Reperfusion therapy for ST elevation acute myocardial infarction in Europe:description of the current situation in 30 countries. Eur Heart J. 2010;31: 943-57.2. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K,Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M, Vahanian A,Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I,Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Silber S,Aguirre FV, Al-Attar N, Alegria E, Andreotti F, Benzer W, Breithardt O, Danchin N, Di Mario C,Dudek D, Gulba D, Halvorsen S, Kaufmann P, Kornowski R, Lip GY, Rutten F, ESC Committee forPractice Guidelines (CPG). Management of acute myocardial infarction in patients presenting withpersistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation AcuteMyocardial Infarction of the European Society of Cardiology. Eur Heart J. 2008;29: 2909-45.3. Widimsky P, Fajadet J, Danchin N, Wijns W. Stent 4 Life targeting PCI at all who will benefit themost. A joint project between EAPCI, Euro-PCR, EUCOMED and the ESC Working Group on AcuteCardiac Care. EuroIntervention. 2009;4:555-7.4. Andrikopoulos G, Pipilis A, Goudevenos J, Tzeis S, Kartalis A, Oikonomou K, Karvounis H,Mantas J, Kyrpizidis C, Gotsis A, Paschidi M, Tsaknakis T, Pyrgakis V, Manolis AS, Boudoulas H,Vardas P, Stefanadis C, Lekakis J, On behalf of the HELIOS study investigators. Epidemiologicalcharacteristics, management and early outcome of acute myocardial infarction in Greece. TheHELlenic Infarction Observation Study. Hell J Cardiol. 2007;48:325-34.5. Eagle KA, Goodman SG, Avezum A, Budaj A, Sullivan CM, Lpez-Sendn J. Practice variation andmissed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from theGlobal Registry of Acute Coronary Events (GRACE). Lancet. 2002;359:373-7.6. Zijlstra F, de Boer MJ, Hoorntje JC, Reiffers S, Reiber JH, Suryapranata H. A comparison ofimmediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N EnglJ Med. 1993;328:680-4.7. Vermeer F, Oude Ophuis AJ, van den Berg EJ, Brunninkhuis LG, Werter CJ, Boehmer AG,Lousberg AH, Dassen WR, Br FW. Prospective randomised comparison between thrombolysis, res- 7. cue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospitalwithout PTCA facilities: a safety and feasibility study. Heart. 1999;82: 426-31.8. Keeley EC, Boura JA, Grines C. Primary angioplasty versus intravenous thrombolytic therapy foracute myocardial infarction: a quantitative review of 23 randomized trials. Lancet. 2003;361: 13-20.9. Widimsky P, Budesinsky T, Vorac D, Groch L, Zelizko M, Aschermann M, Branny M, Stasek J,Formanek P, PRAGUE Study Group Investigators. Long distance transport for primary angioplastyvs. immediate thrombolysis in acute myocardial infarction. Final results of the randomized nationalmulticentre trial PRAGUE-2. Eur Heart J. 2003;24:94-104.10. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, Abilgaard U,Pedersen F, Madsen JK, Grande P, Villadsen AB, Krusell LR, Haghfelt T, Lomholt P, Husted SE,Vigholt E, Kjaergard HK, Mortensen LS. A comparison implementation of prehospital diagnosis anddirect referral for primary percutaneous coronary intervention in patients with acute ST-elevationmyocardial infarction. Eur Heart J. 2011;32:430-36.12. Terkelsen CJ, Srensen JT, Maeng M, Jensen LO, Tilsted HH, Trautner S, Vach W, Johnsen SP,Thuesen L, Lassen JF. System delay and mortality among patients with STEMI treated with primarypercutaneous coronary intervention. JAMA. 2010;304: 763-71.13. Laut KG, Kaifoszova Z, Kristensen S. Status of Stent for Life Initiative across Europe. JCardiovasc Med (Hagerstown). 2011;12:856-9.14. Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J,Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N,Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D. Guidelines onmyocardial revascularization. Eur Heart J. 2010;31:2501-55.